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ABSTRACT 
In the present work, a new combination of synthetic and natural biomaterials is proposed for bone 
tissue engineering (BTE) applications. In order to mimic the inorganic and organic phases of bone 
extracellular matrix (ECM), a bioactive glass-ceramic deriving from a SiO2–P2O5–CaO–MgO–
Na2O–K2O parent glass, acting as a substrate in form of a slice, was surface-functionalised with a 
type I collagen-based coating. In particular, the collagen was blended with a water soluble 
polyurethane (PUR), synthesised from poly(ethylene glycol), 1,6-hexamethylene diisocyanate and 
N-BOC-serinol. The PUR was designed to expose amino groups on the polymeric chain, which 
can be exploited for the blend stabilisation through crosslinking. The newly synthesised PUR 
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demonstrated to be non-cytotoxic, as assessed by a biological test with MG-63 osteoblast-like 
cells. The collagen/PUR blend showed good biocompatibility as well. The polymeric coating on 
the glass-ceramic samples was produced by surface-silanisation, followed by further chemical 
grafting of the blend, using genipin as a crosslinker. The glass-ceramic surface was characterised 
at each functionalisation step, demonstrating that the procedure allowed obtaining a covalent link 
between the blend and the substrate. Finally, biological tests performed using human periosteal 
derived precursor cells demonstrated that the proposed polymer-coated material was a good 
substrate for bone cell adhesion and growth, and a good candidate to mimic the composite nature 
of the bone ECM.  
 
1. INTRODUCTION  
Designing a scaffold for bone tissue engineering (BTE) requires a thoughtful selection of the bulk 
biomaterial, taking in consideration that the ideal one should be biocompatible, osteoinductive, 
osteoconductive, biodegradable and bioactive, acting as a temporary artificial extracellular matrix 
(ECM) to guide bone tissue regeneration [1, 2]. The mechanical properties of the final scaffold 
should be comparable with those of bone and they depend on both the intrinsic mechanical 
properties of the starting biomaterials and the selected scaffolding technique, that are influenced 
by the biomaterial processability [3-5]. Furthermore, since the material surface constitutes the first 
interface for cell interactions, the selected biomaterial should be predisposed to the 
functionalisation with bioactive/biomimetic molecules, which are recognised by cells as integrin-
binding domains [6-9]. Therefore, the biomaterial development is a key factor since it will strongly 
influence the mechanical properties, the scaffolding technique, the cell response, and thus the final 
scaffold performance. 
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This research aims to design and develop a new combination of biomaterials that can be employed 
in BTE applications, by the functionalisation of a glass-ceramic substrate with a bioartificial blend 
of type I collagen and a newly-synthesised biocompatible polyurethane (PUR). 
In the effort to mimic the bone ECM, calcium phosphate ceramics represent a logic choice, because 
their composition and structure are similar to those of the bone mineral phase, mainly composed 
by hydroxyapatite [10, 11]. However, synthetic hydroxyapatite is often characterised by larger 
crystals compared to biological apatite making up bone, unless nano-sized but expensive 
hydroxyapatite is used [12]. In this work, we pursued a novel approach based on the use of a 
bioactive glass-derived material that, upon contact with biological fluids, can form a surface layer 
of nano-crystalline hydroxyapatite which closely mimics biological apatite in human bone. CEL2 
is a bioactive glass belonging to the SiO2–P2O5–CaO–MgO–K2O–Na2O system that has shown 
highly attractive properties for BTE, demonstrating good biological responses, good bioactivity, 
and a lower pH change in contact with physiological fluids if compared to other bioactive glasses 
(e.g. 45S5 Bioglass®), due to its tailored composition (monovalent oxide content <20 mol%, P2O5 
content 3 mol%) [13, 14]. CEL2 has been proven to be biocompatible and bioactive even in its 
glass–ceramic form [13, 14]. Moreover, CEL2 glass can be easily manufactured to obtain 
macroporous glass-ceramic scaffolds. CEL2 glass-ceramic scaffolds obtained through polymer 
burning-out, sponge replication, glazing-like technique and combinations of these methods, have 
shown good mechanical properties that can be tuned to mimic those of human trabecular or 
cancellous bone [14-20].  
In the present work, CEL2-derived glass-ceramic substrates (CEL2-GC) were functionalised with 
a type I collagen-based coating, in order to improve the biomimetic properties of the substrate 
material by imitating the composite nature of bone ECM. In fact, type I collagen represents about 
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90% of bone organic matrix and shows a primary role in influencing cell interaction and 
mineralisation [21-23]. In biomedical applications, collagen has been widely employed as 
component of bioartificial blends [24-39], where the combination of synthetic polymers with 
natural ones aims to take advantages of both materials, such as easy processability, possibility to 
add specific functional groups, and low cost of synthetic polymers combined with the high 
biocompatibility of natural ones [40]. A PUR was selected as the second component of the 
bioartificial blend among several biocompatible synthetic polymers, since PURs have 
demonstrated to be promising biomaterials for BTE due to tuneable chemical and mechanical 
properties, and biocompatibility [35-42]. The PUR was designed to be water soluble with the aim 
to blend it with type I collagen using water as solvent. The selected macrodiol was therefore 
poly(ethylene glycol) (PEG), that is hydrophilic, non-immunogenic and non-toxic [41, 42]. 1,6-
hexamethylene diisocyanate (HDI) was chosen as aliphatic diisocyanate because it has been 
already successfully employed in the synthesis of PURs [43-47], and it leads to non-toxic 
degradation products [48-50]. 
N-BOC-Serinol was selected as chain extender because it has two hydroxyl groups, which can 
react with the diisocyanate, and one protected amino group [46, 51]. The amino group in N-BOC-
Serinol was protected during the synthesis by the presence of the tert-butyloxycarbonyl protecting 
group, the so-called BOC group. After the synthesis, the amino groups were deprotected through 
a mild treatment under acid conditions. 
The free amino groups were employed to covalently link the polymeric blend to the inorganic 
CEL2-derived substrate. The surface of the glass-ceramic material was functionalised by a 
silanisation treatment in order to expose amino groups. The PUR was blended with type collagen 
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I and the bioartificial blend was then covalently linked to CEL2-GC substrate using genipin as a 
bridge between amino groups on the silane and those contained in the polymers chain [52].  
The capability of the proposed biomaterials to properly interact with the cell environment was 
ascertained with the use of human periosteal derived precursors cells (PDPCs), which have shown 
to be a suitable cell source for BTE [53].  
The purpose of this study was to investigate the effect of the functionalisation of CEL2 glass-
ceramic with a newly designed collagen/PUR blend. The hypothesis was that the presence of the 
coating would improve the cell response on the material, providing a biomimetic environment that 
mimics both the organic and inorganic phases of bone. To the best of the authors’ knowledge, it is 
the first time that a biomimetic collagen type I/PUR blend was used to mimic bone ECM and to 
coat a bioactive glass-ceramic for possible applications in BTE. 
 
2. MATERIALS AND METHODS  
2.1. Materials 
All reagents, solvents and raw materials (including oxides and carbonates for bioactive glass 
production) were purchased from Sigma Aldrich in the analytical grade. Trypsin, ethylenediamine 
tetraacetic acid (EDTA), 3-dimethylthiazol-2,5-diiphenyltetrazolium bromide (MTT), 
glutaraldehyde, cacodylate buffer, osmium tetroxide were also purchased from Sigma Aldrich. 
Genipin was purchased from Challenge Bioproducts Ltd. (Taiwan). Glass coverslips were 
purchased from VWR (UK). A human osteoblast-like cell line MG-63 was purchased from ATCC, 
Rockville (MD); Dulbecco’s Phosphate-Buffered Saline (D-PBS), Dulbecco’s Modified Eagle 
Medium/Nutrient Mixture F-12 (DMEM/F12), fetal bovine serum (FBS), nonessential 
aminoacids, L-glutamine, and penicillin–streptomycin were purchased from GIBCO®, Life 
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Technologies (Italy). Mouse anti-human CD90-fluorescein isothiocyanate (FITC) was purchased 
from StemCell Technologies (Milan, Italy), CD105-FITC, CD14-FITC, CD19-FITC, mouse anti-
human CD34-phycoerythrin-(PE), CD45-PE, anti HLA-DR-PE from Diaclone (France), and 
CD73-PE from Becton Dickinson. 
2.2. Polyurethane BOC-SHE1500 synthesis 
PEG-diol (Mn = 1500 Da) was dried at 100 °C for 12 h and, before use, the temperature was 
decreased to 40 °C under dynamic vacuum. The N-BOC-serinol was dried under reduced pressure 
at 40 °C overnight to remove residual water before use. HDI was purified by distillation under 
reduced pressure. 1,2- dichloroethane (DCE) was azeotropically dried by refluxing under nitrogen 
over activated 4 Å molecular sieves for at least 24 h to remove any trace of water. 
The newly-synthesised PUR was denoted as BOC-SHE1500, where BOC-S corresponds to N-
BOC-Serinol, the letter H corresponds to HDI, while E1500 refers to PEG-diol with Mn = 1500 
Da. 
The PUR synthesis was performed by two-step polymerisation in inert atmosphere as shown in 
Scheme S1. In the first step, PEG was dissolved in anhydrous DCE (50% wt/v). The HDI was then 
added (2:1 molar ratio with respect to PEG-diol) to the solution and reacted with the macrodiol in 
the presence of dibutyltindilaurate as a catalyst to form the urethane bonds. The first step was 
carried on for 30 h at 100 °C. In the second step, the chain extender was dissolved in anhydrous 
DCE at 60 °C and added at 1:1 molar ratio with respect to the macrodiol, thus forming further 
urethane bonds. After 2 h the temperature was decreased to room temperature and, after 14 h, the 
reaction was stopped by introducing methanol as a chain terminating agent. The polymer was then 
collected by precipitation in petroleum ether. 
7 
 
The PUR was then dissolved in DCE and purified by precipitation in a non-solvent (solvent/non-
solvent ratio 1:5 v/v) mixture of diethyl ether and ethanol (ratio 95:5 v/v). The obtained polymer 
was dried under vacuum. 
2.3. Deprotection of polyurethane side-chain BOC groups 
The deprotection reaction was performed in order to remove PUR side-chain BOC groups from 
the polymer side chain. 
The newly-synthesised PUR BOC-SHE1500 was dissolved in chloroform (0.55% wt/v), then 
trifluoroacetic acid (TFA) was added (10% v/v of the final solution). The deprotection reaction of 
amino groups was carried out for 30 min at room temperature under nitrogen flow. 
The chloroform/TFA solution was removed by evaporation at 40 °C under reduced pressure. In 
order to eliminate TFA residues, the polymer was dissolved again in chloroform (0.55% wt/v), and 
the solvent evaporated at 40 °C under reduced pressure.  
An aqueous solution of the deprotected PUR (1% wt/v) was then dialysed using a 5 kDa cellulose 
dialysis tube immersed in water for 72 h at 4 °C. Finally the solution was freeze-dried. A further 
purification was performed by washing the polymer in anhydrous diethyl ether overnight under 
nitrogen atmosphere. The deprotected polymer was referred to as SHE1500. 
2.4. Functionalisation of glass-ceramic samples by bioartificial blend 
CEL2-GC slices were produced as described elsewhere [14]. Before the functionalisation 
treatment, the CEL2-GC surface was cleaned by immersion in a highly acidic piranha solution 
(75% H2SO4, 30% H2O2) [54] for 1 h in order to both remove contaminants and activate hydroxyl 
groups on the surface and, eventually, it was rinsed three times in ultrapure water and dried at 100 
°C. The samples were then silanised with 2% 3-aminopropyltriethoxysilane (APTES) in 1,4-
dioxane solution for 3 h and thermally treated at 100 °C for 1 h to stabilise the silane bonding on 
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the CEL2-GC surface. Afterwards, the samples were sonicated three times for 5 min in 1,4-dioxane 
to remove the residual APTES which was not bonded. The substrates were then soaked in 5 mg/ml 
genipin solution in pure water for 1 h at 37 °C [55].  
The bioartificial blend solution (1 mg/ml) was prepared mixing for 24 h at 4 °C the newly-
synthesised and deprotected SHE1500 PUR with type I collagen at concentration of 50:50 (wt:wt), 
adding 2.5%wt genipin as cross-linker [56]. The soluble  type I collagen was isolated from New 
Zealand rabbits’ bones as described by Ferreira et al. [23]. 
The CEL2-GC substrates were functionalised with the bioartificial blend by being soaked in the 
solution for 24 h at 37 °C and dried for 1 h at 37 °C to consolidate the bonding between the genipin 
grafted on the surface and the amino group of collagen and deprotected PUR. Then the samples 
were rinsed in pure water to remove non-bonded molecules and dried again. 
The same functionalisation process was also performed on commercial circular borosilicate glass 
coverslips – which are commonly used for microscopy - in order to characterise the polymeric 
blend alone, bonded to an inert substrate. 
2.5. Sterilisation of the samples 
The samples employed for the in vitro tests were sterilised in order to prevent biological 
contaminations. CEL2-GC slices and glass coverslips, functionalised and not, were sterilised to 
each side for 20 minutes under ultraviolet light. 
2.6. Characterisation tests 
2.6.1. Infrared spectroscopy 
The structure of the synthesised PUR as well as the intermediate products obtained at each 
synthesis step were characterised by Attenuated Total Reflectance Fourier Transform Infrared 
spectra (ATR-FTIR) at room temperature in the spectral range from 4000 to 400 cm-1, employing 
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a Perkin Elmer Spectrum 100 equipped with an ATR accessory (UATR KRS5) with diamond 
crystal. 
All the spectra were obtained as a result of 32 scans with a resolution of 4 cm-1 and analysed by 
Perkin Elmer Spectrum Software. 
2.6.2. FTIR microspectroscopy and chemical imaging 
The micro-ATR (µATR) and spotlight FTIR spectra and maps were carried out by means of a 
Perkin Elmer Spectrum One FTIR Spectrometer; the apparatus was equipped with a Perkin Elmer 
Universal ATR Sampling Accessory and a Perkin Elmer Spectrum Spotlight 300 FT-IR Imaging 
System, using the “image” mode of the instrument. For each sample, an area of 1 mm × 1 mm was 
defined to cover all the structures present in the coated samples, and an IR image was produced 
using a nitrogen-cooled, 16-pixel mercury cadmium telluride line detector at a resolution of 25 µm 
per pixel. An absorbance spectrum was recorded for each pixel in the µATR mode, the spectra 
generated from the surface layers of the sample were collected, and IR spectral images were 
produced. The spotlight software (PerkinElmer, Norwalk, CT) used for the acquisition was also 
employed to pre-process the spectra. The spectral images were analysed with a reference 
correlation image. The obtained correlation map indicates the areas of an image where the spectra 
were most similar to a reference spectrum. Before capturing the IR image, the ZnSe window was 
measured as a reference, and a background spectrum was collected for each of the 16 pixels. All 
spectra were recorded in the mid infrared region (4000–750 cm-1) at 16 scans per pixel; the spectral 
resolution was 4 cm-1; the spatial resolution was 100 × 100 µm. The spectra were also subjected 
to a Savitzky Golay smoothing procedure (9 points). The full spectral maps were analysed through 
Principal Component Analysis (PCA). In this case, the data set was constituted by the spectra that 
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make up the full spectral image. In the PCA map, the spectra data groupings of similar variability 
are represented with the same colour, allowing the identification of different spectral groups. 
2.6.3. Nuclear Magnetic Resonance spectroscopy (NMR) 
1H and 13C NMR spectra were recorded with Bruker Avance III spectrometer operating at 11.74 T 
(corresponding to Larmor frequencies of 125 MHz and 500 MHz for 13C and 1H respectively) 
equipped with a double resonance Z-gradient 5-mm BBFO probe. Chemical shifts were reported 
in parts per million (ppm) relative to tetramethylsilane and were referenced using the residual 
proton solvent resonances. Spectra were measured at 300 K using dimethyl sulfoxide-d6 (DMSO-
d6) as solvent. Spectra assignments were confirmed on heteronuclear single quantum coherence 
(HSQC) experiment. 
2.6.4. X -ray photoelectron spectroscopy  
X-ray photoelectron (XPS) analysis (Al source, M-Probe, Surface Science Instruments) were 
performed employing a monochromatic AlK radiation (15 kV) as source. The single-region was 
acquired using a spot size of 500 µm x 500 µm and a pass energy of 23.5 eV. The collected spectra 
were then analysed using MultiPack software. 
2.6.5. X -ray diffraction  
Wide-angle X-ray diffraction (XRD) analysis (2θ = 10-70°) was carried out by adopting the Bragg-
Brentano camera geometry and Cu-Kα incident radiation (λ = 0.15405 nm); the generator settings 
were fixed at 40 kV (voltage) and 30 mA (current intensity). The angular resolution was Δ(2θ) = 
0.02° and the sampling time was 1 s per step. The collected data were analysed by PANalytical 
X’Pert HighScore program, based on PCPDFwin database, for the identification of crystalline 
phases. 
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2.6.6. Contact angle measurements 
Contact angle measurements were performed using CAM 200 KSV Instrument, equipped with 
Tetha software. Static water contact angle was measured using the sessile drop method (5 μl Milli-
Q water drops) at room temperature. 
2.6.7. Scanning electron microscopy (SEM) and energy dispersive X-ray analysis (EDX) 
The morphological characterisation of the biomaterials was performed by SEM (Philips 525 M 
instrument operating at 15 kV) and by field emission scanning electron microscopy (FESEM, Zeiss 
SUPRA™ 40). Before the analyses, the samples were metal-coated by a thin film of silver or 
chromium (maximum 30 nm in thickness). The chemical composition of samples was assessed 
through energy dispersive X-ray analysis (EDX) by using a Philips EDAX 9100 instrument 
coupled with the SEM. 
These analysis techniques were also applied to investigate the samples after biological tests. After 
the cell cultures, the cell-material constructs were fixed in 2% v/v glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4) for 1 h at 4 °C and post-fixed in 1% v/v osmium tetroxide for 1 h at 4 
°C. Then the samples were dehydrated for 15 minutes at 4 °C in a series of increasing ethanol 
concentrations (from 25% to absolute ethanol), critical point dried using CPD 010 Balzers 
Instruments (FL-9496 Balzers, Liechtenstein) according to the manufacturer’s instructions, 
mounted on aluminium stubs and gold-sputtered (Edwards Sputter Coater B150S). 
Samples were observed with a Philips XL 20 SEM (FEI Italia SRL, Milan, Italy) equipped for X-
ray microanalysis (EDS-PV 9800). Specimens were observed using the secondary electron 
detector. The EDX control program was used for collecting spectra and EDX mapping was applied 
to determine elemental distribution. Operating conditions for the analysis were: voltage 20 kV, 
magnification 500×, counts per second (cps) no less than 2.000, tilt angle 15°, time count 250 s. 
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Only the Kα values of each element were considered and the semi quantitative percentage 
concentrations were calculated using the ZAF (Z = atomic number; A = adsorption; F = 
fluorescence) procedure correction. 
2.6.8. In vitro bioactivity 
The bioactivity studies were carried out in vitro by soaking the samples for 3 and 7 days in 
simulated body fluid (SBF), prepared according to Kokubo’s protocol [57]. Specifically, CEL2-
GC with and without the bioartificial coating were soaked in 25 ml of SBF at 37 °C. The SBF was 
changed every 2 days to simulate the fluid circulation in the body [14, 58] and to keep a constant 
concentration of the cations in the solution. At each time point, the samples were extracted from 
the SBF solution, gently washed with distilled water, and left to dry at room temperature for 48 h. 
Then, the samples were characterised through SEM, EDX, and XRD in order to evaluate the 
morphological and chemical properties of the new phases formed on their surface. 
2.6.9. MG-63 cell culture 
Human osteoblast-like cell line MG-63 was cultured in DMEM supplemented with 10% FBS, 1% 
nonessential amino acids, 2.0 mM L-glutamine, and 1% penicillin–streptomycin (100 U/ml) in a 
controlled atmosphere (5% CO2; T=37°C). The thawed cells were routinely split 1:10 every 3–4 
days and used between the third and fourth passages. 
2.6.10. Harvesting and characterisation of human periosteal derived precursor cells (PDPCs)  
The periosteal tissue was collected from 6 donors (4 males and 2 females, mean age 34 years) 
undergoing surgery for orthopaedic trauma, as previously described [59]. As the study did not 
expose the subjects to any risk, instead of a written consent form, a verbal authorisation was 
obtained from all the recruited patients, in agreement with the Ethical Committee guidelines of the 
Università Politecnica delle Marche where the experiments were performed. 
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Briefly, periosteal explants were washed thrice with D-PBS lacking in Ca2+ and Mg2+, aseptically 
cut into small pieces (4-9 mm2), and then positioned in a 100-mm culture dish in DMEM/F-12 
supplemented with 10% FBS and 1% penicillin-streptomycin (100 U/ml) in a humidified incubator 
at 37 °C with a 5% CO2. The medium was changed every 2-3 days, cells were characterised and 
then used at the 3rd-4th passage of subculture. 
Cell phenotype was assessed using flow cytometry according to the criteria established by The 
International Society for Cellular Therapy for identification of human mesenchymal stem cells 
[59, 60].  
2.6.11. Cytotoxicity evaluation on polyurethane samples 
A SHE1500 solution (100 μg/ml) was prepared by dissolving polymer powders in DMEM 
supplemented with 10% FBS, 1% nonessential aminoacids, 2.0 mM L-glutamine, and 1% 
penicillin–streptomycin and it was maintained for 24 h in a humidified incubator (5% CO2, T= 37 
°C). To evaluate PUR cytotoxicity the following concentrations were tested: 100, 75, 50, 30, 20, 
10, 5, and 1 μg/ml. 
MG-63 cells were seeded at a density of 7.5×103 cells/cm2 into a 24-well polystyrene plate in 
triplicate and incubated for 24 h at 37 °C to allow cell adhesion, then the culture medium in each 
well was replaced with PUR solution (pure or opportunely diluted with fresh culture media). Cells 
were further cultured for 24 h at 37 °C. MTT viability test was performed as described in the 
section 2.6.13. 
2.6.12. Cell seeding 
In order to assess cytotoxicity or biocompatibility, materials were placed in 24-well polystyrene 
plates (Corning® ultra-low attachment) and incubated in appropriate media supplemented with 
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10% FBS and 1% penicillin-streptomycin (100 U/ml) at 37 °C. After 30 minutes, the medium was 
removed and the materials were considered ready for seeding.  
MG-63 cells were detached from culture flasks using 0.25% trypsin in 1 mM EDTA and seeded 
on collagen/PUR coatings (grafted on glass coverslips as described in the section 2.4) at a density 
of 1×104 cells/cm2 in a final volume of 50 μl per sample. After 30 minutes of incubation at 37 °C, 
necessary to ensure cell adhesion and to prevent sliding off and falling in the wells, 1.5 ml of 
DMEM was added in each well and then the samples were further cultured for 2 and 7 days. 
PDPCs were detached from culture flasks as described above and seeded on CEL2-GC or 
collagen/PUR-functionalised CEL2-GC slices at a density of 5 × 103 cells/cm2 in a final volume 
of 50 μl per sample. 1.5 ml of DMEM/F-12 was added in each well after 30 minutes, then the 
samples were further cultured for 1, 2, 5, 7, 14, 21, and 28 days. 
In all the experiments, internal controls were represented by the same cell cytotypes seeded directly 
into 24-well polystyrene culture plates at the same density used for samples and for the same time 
points. 
2.6.13. MTT viability assay 
After each experimental time point, culture media were replaced with 2 ml of 0.5 mg/ml MTT 
solution in phenol red-free DMEM. The multi-well plates were then placed in a humidified 
incubator at 37 °C for 3 h. After removing the supernatants, the dark blue formazan crystals were 
dissolved by adding 2 ml of solvent (4% HCl 1N in isopropanol) and their absorbance was 
quantified spectrophotometrically at 570 nm (Secoman, Anthelie light, version 3.8, Contardi, 
Italy). 
The means and standard deviations were obtained from three samples of the same type. Data were 
expressed as percentage over respective (i.e. MG63 and PDPCs) control cultures.  
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2.6.14. Statistical analysis 
All data were expressed as mean ± standard deviation from at least three samples. Differences 
between means were analysed by one-way ANOVA followed by a Tukey’s post-hoc test. Cell 
culture results were analysed by one-way ANOVA, Student-Newman-Keuls’s and Student’s t-
tests. Statistical significance was set at p < 0.05. All statistical analyses were performed with Prism, 
Graph Pad Software. 
 
3. RESULTS AND DISCUSSION 
3.1. Polyurethane structure characterisation 
The PUR synthesis via the prepolymer method was monitored by ATR-FTIR (Figure 1). In the 
first step, the reaction between the macrodiol (PEG) and the HDI diisocyanate led to the formation 
of urethane groups, as confirmed by the appearance of the strong peak at 1700 cm-1, assigned to 
C=O stretching (amide I), the peak at 1530 cm-1, ascribed to N-H bending, and the peak at 1240 
cm-1 assigned to C-O-C urethane groups [61]. 
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Figure 1: FTIR spectra of the macrodiol (PEG), the prepolymer and the PUR BOC-SHE1500 (ν 
= stretching, δ = bending, w = wagging). 
The intensity increase of these peaks in the second step of the reaction demonstrates that the 
prepolymer reacted with N-BOC-Serinol, and the chain was extended. Moreover, the prepolymer 
FTIR spectrum showed a peak at 2270 cm-1 (indicated as * in Figure 1), assigned to the isocyanate 
group; in contrast, this peak was not present in the FTIR spectrum of the polymer. This result 
confirms that the prepolymer was still reactive and the residual isocyanate reacted quantitatively 
with the chain extender during the second step. The chemical structure of the PUR was also studied 
through NMR (Figure 2).  
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Figure 2: NMR spectra of the newly synthesised polymer BOC-NSHE1500 before (on the left) 
and after (on the right) the deprotection of amino groups. For each polymer the 1H (A, B) and 13C 
(C, D, E, F) NMR spectra are reported. 
 
1H NMR spectrum of BOC-SHE1500 (Figure 2A) showed three resonances at 1.22 ppm, 1.37 ppm 
and 2.93 ppm due to the methylene protons of the HDI portion of the polymer. The signals of the 
PEG portion of the polymer appeared at 3.51 ppm, 3.55 ppm and 4.03 ppm. The serinol moiety 
showed two resonances at 3.36 ppm and at 3.55 ppm, the last one overlapped to PEG protons. The 
signal of the methyl protons of the BOC protecting groups fell at 1.37 ppm as sharp singlet, 
completely overlapped to one of the HDI signals. 
In the 13C NMR spectrum (Figure 2C and E) the HDI signals of BOC-SHE1500 were at 26.0 ppm, 
29.3 ppm and 40.1 ppm. The PEG portion of the polymer showed three resonances at 62.9 ppm, 
68.9 ppm and 69.8 ppm. The serinol fragment showed two signals at 51.8 ppm and 60.6 ppm. The 
urethane carbonyl carbons appeared at 156.1 ppm. The BOC protecting groups signals were at 
28.2 ppm, 77.7 ppm and 155.2 ppm.  
There was no signal at 122 ppm, indicating the absence of unreacted isocyanate groups at the end 
of the reaction, as assessed also by ATR-FTIR analysis.  
NMR was also employed to evaluate the PUR chemical structure after the deprotection reaction. 
1H NMR spectrum of SHE1500 (Figure 2B) showed three resonances for the HDI unit of the 
polymer at 1.22 ppm, 1.37 ppm and 2.93 ppm. The PEG portion signals were 3.51 ppm, 3.54 ppm 
and 4.03 ppm. The serinol fragment showed two signals at 3.36 ppm and 3.55 ppm partially 
overlapped to water and PEG signals respectively. The sharp signal at 1.37 ppm due to BOC 
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protons almost disappeared, indicating a successful polymer deprotection of over 90% of the BOC 
groups. 
In the 13C NMR spectrum of SHE1500 (Figure 2D and F) the signals at 25.9 ppm, 29.3 ppm and 
40.1 ppm belonged to the HDI unit of the polymer. The PEG portion showed three signals at 62.9 
ppm, 68.9 ppm and 69.8 ppm while the serinol unit had two resonances at 51.5 ppm and 58.5 ppm. 
The signal at 156.1 ppm was due to urethane carbonyl carbons.  
The three resonances of the BOC protecting group were no more present in the spectrum, thus 
confirming the amino group deprotection. 
The expected structure of the new deprotected SHE1500 was confirmed by both the 1H and 13C 
NMR results. 
3.2. Functionalisation of glass-ceramic samples  
The cleaning treatment on CEL2-GC performed by immersion in piranha solution allowed removal 
of contaminants and activation of reactive –OH groups, since the acid environment of this 
treatment led to an ionic exchange in the CEL2-GC surface [62]. The contaminant removal from 
CEL2-GC substrates produced a hydrophilic surface, as assessed by contact angle measurements 
(from around 35° to around 8°) summarised in Figure 3. 
20 
 
 
Figure 3: Contact angle measurements at each step of functionalisation. Results are expressed as 
mean ± standard deviation. Statistically significant difference between values are marked with *** 
(p < 0.001) and **** (p < 0.0001). 
After exposure of the hydroxyl groups, the samples were silanised by APTES and the surface 
showed a higher contact angle (~32°) because, according to literature [62, 63], the introduction of 
silane molecules carries a less hydrophilic tendency of the surface. The comparison of the 
wettability of CEL2-GC surface (~35°) and CEL2-GC functionalised with the bioartificial blend 
(~37°) did not show any statistically significant difference. The wettability of a solid is directly 
correlated to its surface energy, which in turn influences the cell adhesion to the substrate [64]. 
Both substrates (CEL2-GC as-such and CEL2-GC functionalised with the blend) showed good 
wettability. Surfaces with good wettability have shown to induce protein absorption in their natural 
conformation, allowing the interaction with cell integrins and resulting in a positive cell adhesion 
and spreading [65-70].  
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Both substrates (CEL2-GC as-such and CEL2-GC functionalised with the blend) showed good 
wettability, which is an important feature to positively influence cell adhesion and spreading. 
The effectiveness of the functionalisation procedure was confirmed by XPS analyses. The atomic 
percentages of the elements of interest, detected on CEL2-GC surface at each step of 
functionalisation, is reported in Table 1. The increasing amount of organic material grafted on the 
surface was consistent with the increasing percentage of carbon and decreasing percentage of 
detected silicon of the glass. 
Table 1: XPS atomic percentage of elements of interest in the samples analysed 
Element 
Atomic % 
CEL2-GC after 
piranha treatment 
CEL2-GC after 
silanisation 
CEL2-GC grafted 
with genipin 
Collagen/PUR 
functionalised 
CEL2-GC 
O 60.8  47.2 34.3 28.6  
C 12.2  27.9 49.4 58.1 
Si 24.4 13.3 10.4 5.7 
N 0.1 5.6 5.6 7.6 
 
In the first step, the CEL2-GC surface was subjected to piranha treatment in order to remove 
contaminants from the surface. The detailed analysis of the carbon region (Figure 4A) showed 
three peaks at around 283, 284 and 285 eV, due to an unavoidable hydrocarbon contamination 
from the atmosphere [63]. The treatment exposed –OH groups as confirmed by the high atomic 
percentage of oxygen on the surface (Table 1). 
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Figure 4: XPS high-resolution spectra of (A, B, C, D) carbon and nitrogen regions of samples (A) 
after piranha treatment, (B, E) after silanisation, (C, F) after genipin grafting, and (D, G) 
functionalised with collagen/PUR blend. 
The silanisation treatment was performed on the rinsed-CEL2-GC surface in order to link the 
APTES and expose free amino groups for further functionalisation steps. After this procedure, 
XPS detected the presence of nitrogen on the surface, which was previously absent in the rinsed 
CEL2-GC (Table 1). The detailed analysis of nitrogen region (Figure 4E) showed a mono-
energetic peak at about 399 eV, suggesting that there was only one chemically distinguishable 
form of nitrogen on the surface, attributed to the amino groups exposed by silane [71, 72]. 
The detailed analysis of carbon region showed a mono-energetic peak at about 285 eV, attributed 
to both hydrocarbon contaminations from atmosphere [63] and C-C bond present in the APTES 
molecule (Figure 4B). These results confirmed the success of the silanisation process. 
Genipin was then grafted on the surface in order to link the free amino group exposed by the 
APTES molecule with the amino groups of collagen and PUR SHE1500. 
The link between amino group and genipin may involve two different sites of the molecule, 
following two diverse reactions, as described by Butler et al. [52]. The first reaction that occurred 
led to the formation of a heterocyclic compound of genipin linked to the silane molecule, due to 
the nucleophilic attack of the genipin C3 carbon atom from the silane amino group, , resulting in 
the opening of the dihydropyran ring and the formation of an intermediate aldehyde group. Then, 
the attack of the aldehyde group from the secondary amine (formed in the first step of the reaction) 
led to the ring closure [52]. After the binding between APTES amino groups and genipin, the N1s 
region showed a more complex signal (Figure 4F), which was deconvoluted in the contribution of 
three peaks. The peak at about 399 eV, as observed for silanised samples, was attributed to amino 
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groups exposed by silane on the surface. The peaks at about 400 eV and 401 eV were assigned to 
nitrogen in pyridine ring [73] and NHCO [71], respectively. 
The detailed analysis on C1s region (Figure 4C) showed a more complex signal, due to the 
contribution of three peaks at about 284.6 eV (C-C), 285.9 eV and 288.1 eV. The last two peaks 
were not present in the silanised CEL2-GC, and can be attributed respectively to C-COOR and 
COOR of genipin molecule [55]. Consequently, the reactive ester group of genipin was exploited 
as second reactive site to link the bioartificial blend [52]. The appearance of the peak at about 289 
eV in the C1s spectral region, attributed to the C1s peptide component [55], demonstrated the link 
between collagen/PUR free amino groups and reactive ester groups of genipin (Figure 4D). These 
results are consistent with previous studies where genipin was employed to crosslink materials 
containing primary amine groups [52, 55].  
The functionalisation of CEL2-GC resulted in a change of colour of the substrate (Figure S1). The 
glass-ceramic was in fact white, as a result of the formation of the crystalline phases during the 
thermal treatment of CEL2 glass (Figure S1A). After the genipin grafting, the substrate colour 
changed to brown (Figure S1B), due to the link of genipin C3 carbon with amino group exposed 
from the silane. Finally, when genipin was crosslinked, the colour changed to dark blue (Figure 
S1C): this effect is due to crosslinking of genipin primary amines in presence of oxygen [52]. 
Morphological investigations of as-such and coated CEL2-GC slices are reported in Figure 5. In 
good agreement with previous results [14], the presence of two different crystalline phases was 
noticed: the first one was characterised by tetragonal crystals with sharp edges (Figure 5A and B), 
meanwhile the second one was needle shaped (Figure 5C). Figure 5D shows the surface of CEL2-
GC functionalised with the collagen/PUR coating, which resulted homogenous on the substrate 
area. 
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Figure 5: SEM micrographs of CEL2-GC slices before (A, B, C) and after (D) the 
functionalisation with the bioartificial blend. A and B) CEL2-GC tetragonal crystalline phase 
(800× and 3000× respectively). C) CEL2-GC needle shaped crystalline phase (1600×). D) CEL2-
GC functionalised with the coating (2500×).  
 
The structural and chemical organisation of the blend coating on CEL2-GC was investigated 
through chemical imaging. The results of µATR/chemical imaging performed on CEL-GC are 
reported in Figure 6A, B and C. The surface of the CEL2-GC sample was not perfectly flat, thus 
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producing a colour variation in the chemical map (Figure 6A) due to the different pressure of the 
crystal on the sample. In fact, the red indicates the zones where the crystal induced a higher 
strength compared to the blue ones. The average spectrum characteristic of the CEL2-GC surface 
in the considered area is reported in Figure 6B. The absorption spectrum showed a small band at 
1164 cm−1 corresponding to the stretching of the P=O link. The big band at 1005 cm−1 was assigned 
to the Si–O–Si asymmetric stretching of bridging oxygen atoms within the tetrahedron. The band 
at 911 cm−1 corresponds to the P–O stretching and the Si–O–Si stretching of non-bridging oxygens 
[74]. By comparing all the spectra acquired in the selected area with the average spectrum, it was 
possible to obtain the correlation map reported in Figure 6C. The correlation was close to 1 in all 
the surface analysed, indicating a high homogeneity of the sample surface chemistry. 
The sample functionalised with the bioartificial blend was characterised in the same way and the 
results are reported in Figure 6D, E and F. 
In the spectra acquired in the map (Figure 6E), it was possible to observe absorption bands at 3291 
cm-1, assigned to the N-H stretching vibration of amide A, and a peak at 2925 cm–1 related to 
asymmetrical stretch of CH2 (amide B) [75]. The amide I band was found at 1645 cm
-1 (C=O 
stretching vibrations) [76], the amide II was found at 1547 cm-1 (N-H bending and C-N stretching) 
[77], and the peak at 1060 cm-1 was attributed to the overlapping of the peaks associated to C-O-
C and the stretching of C–O of carbohydrate moieties (due to the proteoglycan) [78]. The 
correlation map (Figure 6D) was obtained comparing all the spectra acquired in the selected area 
with the average spectrum. This map showed a large zone with values close to 1, where it was 
possible to identify the characteristic collagen bands. However, the spectra acquired in this zone 
presented a variability in the intensity of the band assigned to amide I and II (Figure 6F). 
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In order to gain more detailed information about the bioartificial coating composition, smoothing 
procedures were carried out and the second derivative of the maps was calculated to identify the 
overlapping components under the band at 1060 cm-1 (Figure S2).  
The second derivative spectra showed a bands at 1080 cm-1, characteristic of the PUR SHE1500, 
and a band at 1049 cm-1, due to the polysaccharide component present in the isolated type I 
collagen. It can be noticed that the peak characteristic of PUR C-O-C group shifted to a lower 
wave number (1080 cm-1). This shift can be due to further interactions between the blend 
components induced by the cross-linking with genipin, suggesting that the stabilisation of the 
protein was produced thanks to the presence of the polysaccharide component in the isolated 
collagen, and the re-arrangement induced by the cross-linking with genipin promoted the 
formation of interaction among PUR C=O groups and proteoglycans. 
The results were statistically elaborated through PCA in order to identify the zones on the map 
with the same spectral variability (Figure 6G, H and I). The PCA evaluation showed the presence 
of three spectral groups, corresponding to a non-coated zone (green, with a score of 45%), a 
homogenously coated zone (red, with a score of 55%), and two zones where there was a higher 
concentration of collagen (blue, with a total score of 1%). In the red zone, the coating showed a 
homogenous composition and the presence of both collagen and PUR. 
Finally, in order to determine if the ratio between collagen and PUR was constant in the coating, 
the peak corresponding to the amide I was taken as a reference for the collagen, and the band at 
950 cm-1 was selected as a reference for the PUR SHE1500. Then, a map representing the ratio 
between the two bands was acquired (Figure S3). In the zone of the sample where the coating was 
homogenous (red zone in Figure 6G), the ratio between the two bands was almost constant, being 
included in a range from 0.2 to 0.4. 
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Figure 6: Investigation through µATR -chemical imaging of CEL2-GC (A, B, and C) and CEL-
GC functionalised with the collagen/PUR blend (D, E, and F) and statistical evaluation through 
PCA of the results obtained on the functionalised samples (G, H and I). A) Chemical map on the 
CEL2-GC’s surface. B) Average spectrum on CEL2-GC (ν = stretching). C) Correlation map on 
CEL2-GC surface. D) Correlation map on functionalised CEL2-GC. E) Average spectrum on the 
surface of functionalised samples. F) Spectra acquired in different points of the correlation map 
on functionalised CEL2-GC. The spectrum in pink is the average spectrum. G) Map of the 
functionalised surface investigated through PCA. H) Spectrum acquired at point 1 (blue zone) of 
the map. I) Spectrum acquired at point 2 (red zone) of the map. 
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3.3. In vitro bioactivity 
CEL2-GC already demonstrated to possess apatite-forming properties upon soaking in SBF [14]. 
The aim of this characterisation was to investigate how the surface functionalisation carried out in 
this research work could influence CEL2-GC bioactivity. Therefore, CEL2-GC slices and CEL2-
GC slices functionalised with the bioartificial coating were soaked in SBF in order to investigate 
their in vitro bioactivity by monitoring the modifications that occurred on their surfaces after 3 and 
7 days of incubation.  
After 3 days of soaking in SBF, the presence of a silica gel layer was visible on CEL2-GC surface 
(Figure S4A and C). The silica gel formed as a consequence of the ionic exchange between CEL2-
GC surface and SBF and the following hydrolysis of the silica groups present in the glass network, 
creating silanol groups (Si-OH) which then condensed and polymerised to form a gel layer. 
However, in most of the zones, the silica gel was not visible since it was covered by calcium-
phosphate crystals, as assessed by EDX investigations (Figure S4A, G) and XRD analysis (Figure 
7). 
30 
 
 
Figure 7: XRD patterns of CEL2-GC (A) slice before, (B) after 3 days and (C) 7 days of incubation 
in SBF. 
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The newly formed phase was constituted by globular agglomerates with a ‘‘cauliflower"-like 
morphology typical of hydroxyapatite [79]. The results of XRD analysis on CEL2-GC as-such 
(Figure 7A) showed the presence of two crystalline phases, Na4Ca4(Si6O18) (combeite, JCPDS 
code 01-078-1649, Figure 5B) and Ca2Mg(Si2O7) (akemanite, JCPDS code 01-077-1149, Figure 
5C), in agreement with previous data [16]. The major crystalline phase of CEL2-GC – combeite – 
is the same phase found in crystallised 45S5 Bioglass® [80], which is highly biocompatible, 
bioactive and clinically used for 30 years in million patients to repair osseous defects [81]. The 
XRD spectra of CEL2-GC after 3 days of incubation (Figure 7B) showed the persistence of the 
main peaks of akemanite at 24° and 31°, meanwhile the intensity of combeite peaks significantly 
decreased compared to the spectra of the CEL2-GC before the treatment (Figure 7A). A new broad 
peak was clearly visible at 31.8°, due to the formation of hydroxyapatite crystals (JCPDS code 01-
073-1731) on the sample surface (Figure 7B). This new peak, corresponding to the (211) reflection, 
was broad due to the typical nano-crystalline nature of the hydroxyapatite crystals formed on 
bioactive glasses and glass-ceramics [82]. This is consistent with the mechanism proposed by 
Hench to describe the bioactivity mechanism of silicate biomaterials [83]. After 7 days of 
incubation, the newly formed phase was homogeneously distributed on the surface (Figure S4A, 
B, D, and F). The compositional analysis carried out on this phase, reported in Figure S4A, 
revealed a molar ratio Ca/P ≈ 1.72, which closely approaches the stoichiometric value of natural 
hydroxyapatite (1.67). The presence of chromium (Cr) peaks in EDX patterns was due to the metal 
coating necessary for analysis. At this time point, the peaks corresponding to the crystalline phases 
of heat-treated CEL2 were almost no more visible in the XRD spectra. A broad peak (halo) at 
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around 32°, which is the major peak of hydroxyapatite, was clearly visible (Figure 7C). The “peak 
broadness” was due to the nano-crystalline nature of hydroxyapatite. 
The SEM images of CEL2-GC slices functionalised with the bioartificial coating after 3 and 7 
days of incubation are reported in Figure 8.  
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Figure 8: SEM and EDX characterisation performed on CEL2-GC functionalised with the 
collagen/PUR coating after incubation in SBF. The SEM micrographs were acquired on the 
functionalised CEL2-GC surface after 3 (A, C, E, F) and 7 days (B, D) of incubation in SBF. 
Magnifications: A-B 500×, C-D 2000×, E 10000×, F 40000×. EDX analysis were performed: G) 
after 3 days of incubation on the surface in figure E, H) after 7 days of incubation on the surface 
in figure D. 
 
Compared to the CEL2-GC samples, the functionalisation seemed to induce a faster 
hydroxyapatite layer formation, thus improving the in vitro bioactivity. The piranha treatment was 
employed to expose –OH group on the surface of the samples. This mechanism involved the Na+ 
release from the glass-ceramic substrate and the formation of Si-OH groups on the surface. 
Therefore, the bioactivity mechanism was thought to be sped up thanks to this treatment. The XRD 
spectra corresponding to the functionalised CEL2-GC samples after 3 (Figure 9A) and 7 days 
(Figure 9B) of incubation in SBF presented new broad peaks at 26°, 32°, 46° and 49°, due to the 
presence of hydroxyapatite. Interestingly, the peaks corresponding to the crystalline phases of 
CEL2-GC were less detectable in the collagen/PUR-functionalised CEL2-GC samples, due to the 
presence of the polymeric coating and the hydroxyapatite layer on the sample surface. 
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Figure 9: XRD patterns of CEL2-GC functionalised with the bioartificial blend after A) 3 days 
and, B) 7 days of incubation in SBF. 
 
3.4. In vitro biocompatibility of the CEL2-GC functionalised with the bioartificial 
blend 
Biomaterials that support regenerative processes are a key ingredient for successful bone tissue 
engineering. Indeed, the optimal scaffold structure is still under debate. Among the several 
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characteristics influencing the bone forming capacity of scaffold materials, biocompatibility and 
appropriate surface chemistry that favour for cell adhesion, growth and differentiation are of 
outmost importance [53]. 
Biocompatibility assessment could be performed using commercial cell lines (e.g. MG63, Saos-
2), while investigation on the interaction with bone microenvironment must consider primary cell 
behaviour. It is well established that fracture healing requires the mobilisation of MSCs. These 
cells are recruited locally and concomitantly from the periosteum and bone marrow (BM) during 
bone repair [59]. Both periosteum and BM generate osteoblasts, but these cells showed distinct 
cellular responses in bone healing, with a critical role in new bone tissue mineralisation played by 
PDPCs. Based on these considerations, we assessed the proposed materials using MG63 for the 
screening of PUR and bioartificial blend compatibility, and PDPCs for further investigation.  
The PUR and the bioartificial blend showed good biocompatibility, as reported in the 
supplementary material. 
MTT and SEM observations were performed seeding PDPCs on CEL2-GC up to 28 days of 
culture. Viability test (Figure 10a) displayed a mean value significantly (p<0.05) lower than 80% 
only after 24 h of culture, suggesting a low adhesion of cells during the early hours of culture. 
Afterwards, cell viability significantly (p<0.05) increased up to the 21th days of culture, and then 
a slight decrease was observed again.  
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Figure 10: PDPCs cultured on CEL2-GC samples (a) MTT viability test; SEM micrographs of 
cells after 1 (b), 2 (c), 3 (d), 7 (e), 14 (f), 21 (g) and 28 days (h) of culture. (Scale bars 20 m) 
MTT data are expressed as percentage over PDPCs control cultures. Mean ± standard deviation of 
three samples is reported * p<0.05 vs control culture. 
 
SEM observations were consistent with MTT test data with cells that, over time, tended to cover 
the whole surface of the CEL2-GC samples (Figure 10). As the culture time increased, the surface 
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of the samples resulted covered by the ECM synthesised by PDPCs. Specifically, calcified ECM 
deposited on the sample can be observed after 28 days with a Ca/Si ratio of 0.59 (Table 2).  
Table 2: EDX semiquantitative analysis of Ca/Si ratio after PDPCs culture on the analysed 
samples  
 
Ca/Si weight % 
0 days 7 days 14 days 21 days 28 days 
CEL2-GC  0.22 0.22 0.22 0.27 0.59 
Collagen/PUR 
functionalised 
CEL2-GC 
0.22 0.22 0.28 0.47 1.08 
 
The same analyses were repeated on PDPCs seeded on collagen/PUR functionalised CEL2-GC. 
Viability test (Figure 11a) displayed a mean value higher than 100% only after 1 day of culture, 
suggesting that the presence of the bioartificial blend coating increases initial cell adhesion. Cell 
viability significantly decreased in the next few days up to the 7th day of culture when an increase 
was observed, and this trend continued until day 28.  
SEM observations (Figure 11) evidenced elongated cells at 1 and 2 days from seeding. After 5 
days cells looked more spread and assumed a star-shaped morphology. Evidence of ECM 
deposition was detectable since 7 days of culture and calcium content on the surface of the samples 
significantly increased up to day 28 (Figure 11 inserts). As reported in Table 2 the Ca/Si ratio 
increased over time, which may suggest the deposition of calcium nodules indicating the 
progressive mineralisation of the ECM [73]. 
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Figure 11: PDPCs cultured on functionalised CEL2-GC samples (a) MTT viability test; SEM 
micrographs of cells after 1 (b), 2 (c), 3 (d), 7 (e), 14 (f), 21 (g) and 28 days (h) of culture. (Scale 
bars 50 m) Note the presence of ECM (arrows) deposition after 7 days (f) of culture. ECM 
mineralisation was detected starting from the 14th days of culture (f) as confirmed by EDX 
mapping (inserts f-h): Ca Red, Si green; MTT data are expressed as percentage over PDPCs control 
cultures. Mean ± standard deviation of three samples is reported * p<0.05 vs control culture. 
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PDPCs are multipotent progenitor cells able to differentiate through the osteogenic lineage [84]. 
When the multipotent progenitor cells start the differentiation, they progress through consecutive 
developmental stages of differentiation: proliferation, down-regulation of proliferation, matrix 
maturation, and mineralisation [85, 86]. 
When PDPCs were seeded on CEL2-GC, after a first phase with low adhesion during the early 
hours of culture, the cells started to proliferate until they covered the whole surface of the samples. 
The proliferation phase lasted until the 21st day, when a slight decrease in viability was detected, 
indicating a down-regulation of the proliferation and the beginning of cell differentiation with 
matrix maturation. After 28 days of culture, it was possible to detect calcified deposited ECM, 
showing the beginning of the mineralisation phase. 
On the other hand, when PDPCs were seeded on the functionalised CEL2-GC, higher adhesion 
was detected after 24h suggesting that the presence of the bioartificial blend coating increased the 
initial cell adhesion. These results confirmed the dominant role of the bioartificial blend in 
increasing the efficiency of cell adhesion, thus maintaining the biological and structural integrity 
of ECM. Specifically, the presence of the collagen is known to influence cell adhesion to the 
substrate through the specific interaction of cell’s receptors with this molecule, which presents 
more than 40 ligand-binding sites [87] [REF].The cell viability decrease, up to the 7th day, indicates 
an earlier down-regulation of proliferation. The presence of the bioartificial blend coating induced 
a prior cell differentiation through the osteogenic lineage compared to the cells cultured in the non-
functionalised CEL2-GC. In fact, calcified deposited ECM was found already at the 7th day of 
culture. It has already been reported that collagen-based coatings promote bone cell proliferation, 
adhesion and spreading [88] and it is able to enhance osteogenic cell differentiation [89, 90]. In 
our study Overall, our results confirm the dominant role of the bioartificial blend in increasing the 
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efficiency of cell adhesion, thus maintaining the biological and structural integrity of ECM. It has 
already been reported that collagen-based coatings promote bone cell proliferation, adhesion and 
spreading [88]. The presence of collagen-based coating was reported to enhance osteogenic cell 
differentiation [89, 90]. In this case, the presence of the polymeric bioartificial coating based on 
the newly-synthesised PUR SHE1500 and type I collagen enhanced ECM deposition by PDPCs 
cells and mineralisation. 
 
CONCLUSIONS 
The biomimetic approach is a promising strategy to develop advanced biomaterials for bone 
replacement. In this context, the combination of polymeric and ceramic biomaterials is a key factor 
for mimicking both the organic and inorganic phases of bone ECM. In this paper, the selection of 
a bioactive glass-ceramic as a substrate allowed mimicking the bone inorganic phase. This material 
showed good apatite-forming ability in SBF and good interaction with PDPCs. Bonding a 
PUR/type I collagen bioartificial blend on the glass-ceramic surface improved the biomimetic 
behaviour of the material, imitating bone ECM organic phase. The discussed results, indeed, 
suggested that the selected biomaterials showed appropriate biomimetic properties for potential 
BTE applications. Moreover, a new PUR was synthesised and BOC-deprotected to present free 
amino group in the polymeric chain, which can be exploited for future functionalisation 
approaches such as grafting of specific proteins, growth factors or for drug delivery. PDPCs 
cultured on the functionalised glass-ceramic substrates showed an increased deposition of mineral 
matrix with a higher calcium content. Future experiments will focus on the employment of this 
novel combination of biomaterials for the production of three-dimensional porous scaffolds that 
can be employed for BTE applications. 
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